Date: Tuesday 15 May 2012
Drugs giant GlaxoSmithKline is to take full control of Cellzome, a company specialising in the study of protein structures and functions.
| London midday: Stocks tank again on euro worries | 09-May-2012 | ShareCast |
| London open: Stocks claw back after heavy sell-off | 09-May-2012 | ShareCast |
| London pre-open: Slight rise expected after Tues... | 09-May-2012 | ShareCast |
| Glaxo goes hostile in HGS takeover | 09-May-2012 | ShareCast |
| Thursday broker round-up | 03-May-2012 | ShareCast |
| Director Declaration | 16-May-2012 | 17:20 | RNS |
| Transaction in Own Shares | 16-May-2012 | 17:15 | RNS |
| GSK increases its ownership in Theravance | 16-May-2012 | 14:12 | RNS |
| Transaction in Own Shares | 15-May-2012 | 17:07 | RNS |
| GSK to fully acquire Cellzome | 15-May-2012 | 10:00 | RNS |
| GLAXO GOES HOSTILE IN BID | 10-May-2012 | Express & Star |
| Glaxo wins £1.5m grant | 20-Dec-2011 | The Herald |
| GSK embarks on a new age of discovery | 12-Dec-2011 | Telegraph |
| How boardroom excess is eroding trust in business | 22-Nov-2011 | Guardian |
| GlaxoSmithKline scientists face their own Dragon... | 07-Nov-2011 | Telegraph |
| Questor:GlaxoSmithKline | 06-Oct-2011 | Telegraph |
| Questor:GlaxoSmithKline | 11-Aug-2011 | Telegraph |
| Questor tip: GlaxoSmithKline | 28-Jul-2011 | Telegraph |
| Investment Column: GlaxoSmithKline | 27-Jul-2011 | The Independent |
| Questor : GlaxoSmithKline | 03-May-2011 | Telegraph |
| FTSE 100 preview: Greek delay hits shares | 20-Jun-2011 | This Is Money |
| GlaxoSmithKline gets green light over Potiga | 14-Jun-2011 | This Is Money |
Irish zinc explorer Connemara Mining ... |
11-Jun-2011 | Proactive Investors |
| FTSE preview: Gloom over commodities | 10-Jun-2011 | This Is Money |
| FTSE preview: Shares hit by US jobs woe | 06-Jun-2011 | This Is Money |
| Currency | UK Pounds |
| Share Price | 1,421.50p |
| Change Today | -2.00p |
| % Change | -0.14 % |
| 52 Week High | 1,497.00 |
| 52 Week Low | 1,205.00 |
| Volume | 7,337,610 |
| Shares Issued | 5,036m |
| Market Cap | £71,582m |
| Beta | 0.52 |
| RiskGrade | 74 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 12 |
| Buy | 3 |
| Neutral | 17 |
| Sell | 3 |
| Strong Sell | 0 |
| Total | 35 |

| Latest | Previous | |
|---|---|---|
| Q1 | Special | |
| Ex-Div | 09-May-12 | 15-Feb-12 |
| Paid | 05-Jul-12 | 12-Apr-12 |
| Amount | 17.00p | 5.00p |
| Time | Volume / Share Price |
| 16:51 | 5,600 @ 1,421.15p |
| 16:46 | 435 @ 1,424.00p |
| 16:44 | 4,003 @ 1,421.25p |
| 16:42 | 3,000 @ 1,422.06p |
| 16:36 | 2,500 @ 1,421.50p |
You are here: research